コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s in the care of patients with nondiagnostic lung scans.
2 with decreased perfusion in nuclear medicine lung scans.
3 oppler ultrasound and venography, and repeat lung scans.
4 ions less than -950 Hounsfield units on full-lung scans.
5 of airway remodeling on computed tomography lung scans.
6 ong-term anticoagulation after their initial lung scans, 22 (19%) died, none of whom had PE confirmed
7 0 000 (range, 45 000-159 000) false-positive lung scans, 6000 (range, 6000-7000) colonoscopy complica
8 eported symptoms not previously present, and lung-scan abnormalities were common among those who were
10 nation for the discrepancy between perfusion lung scan and pulmonary angiographic findings in PVOD is
11 inel lymph-node procedures decreased by 45%, lung scans by 56%, bone scans by 60%, myocardial studies
12 E without further diagnostic testing such as lung scanning, chest computed tomography (CT) scanning,
15 n each of 19 bronchopulmonary segments in CT lung scans from 199 patients with asthma, AT was categor
16 igh-probability" ventilation/perfusion (V/Q) lung scans generally indicate proximal pulmonary arteria
17 nterpretation of ventilation/perfusion (V/Q) lung scans, if verified by prospective evaluation to hav
18 gitudinal analysis of baseline and Year 3 CT lung scans in SARP-3 participants, radiologists generate
19 lity interpretation of ventilation-perfusion lung scans in the Prospective Investigation of Pulmonary
20 s of mucus plugs in computed tomography (CT) lung scans in the Severe Asthma Research Program (SARP)-
23 of pulmonary embolism is challenging because lung scanning is nondiagnostic in most patients and beca
24 lowed by whole-body scanning (n = 135, 84%), lung scanning (n = 126, 78%), and virtual colonoscopy (n
25 > 3 small subsegmental defects on perfusion lung scans of patients with suspected acute pulmonary em
26 l diagnostic methods have been described for lung scans, of which the most widely applied uses 99mTc-
27 nterpretation of ventilation/perfusion (V/Q) lung scans on the basis of criteria dependent on whether
28 LISA is as diagnostically useful as a normal lung scan or negative duplex ultrasonography finding.
29 d testing for PE, consisting of radionuclide lung scanning or contrast-enhanced computed tomography a
31 rench Society of Nuclear Medicine to collect lung scans performed on COVID-19 patients for suspected
32 ysis of high-resolution computed tomographic lung scans permits quantitative morphometry of the lung
33 had PE proven by necropsy, high-probability lung scan, pulmonary angiography, or venous ultrasonogra
34 nsity thresholds in computed tomography (CT) lung scans quantify air trapping (AT) at the whole-lung
36 r all patients who had ventilation/perfusion lung scans reported as IP or indeterminate during a 7-yr
38 graphy and venography, ventilation-perfusion lung scan, venous ultrasonography, d-dimer assay, and cl
41 diate probability (IP) ventilation/perfusion lung scans was performed to evaluate: the frequency of d
44 urrent TE disease is low in patients with IP lung scans who are appropriately evaluated and managed a
45 al D-dimer results, fewer chest CT scans and lung scans will be required, and improvements may be rea
46 itive predictive value) for PE and perfusion lung scans with > 3 small subsegmental defects satisfy t
47 ive predictive value for the PE of perfusion lung scans with > 3 small subsegmental defects was 11% t
49 ositive predictive value for PE of perfusion lung scans with 1-3 small subsegmental defects was 1% to